Atai Life Sciences N.V. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q2 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q3 2024 | 3 | -$0.17 | -$0.09 | -$0.14 |
| Q1 2025 | 1 | -$0.17 | -$0.12 | -$0.15 |
| Q2 2025 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q3 2025 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q4 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
Atai Life Sciences N.V. Earnings Date And Information
Atai Life Sciences N.V. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.36 earnings per share for the quarter, missing analysts' consensus estimates of $-0.17 by $0.19. The company had revenue of 0 for the quarter and had revenue of 314,000 for the year. Atai Life Sciences N.V. has generated $0 earnings per share over the last year ($-0.25 diluted earnings per share) and currently has a price-to-earnings ratio of -2.09. Atai Life Sciences N.V. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Atai Life Sciences N.V. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.16 | $0 | $0 | ||
| 08/13/2024 | Q2 2024 | -$0.17 | -$0.36 | -0.19 | $273,000 | $273,000 |
| 05/15/2024 | Q1 2024 | -$0.20 | -$0.17 | 0.03 | $0 | |
| 03/28/2024 | Q4 2023 | -$0.17 | -$0.12 | 0.05 | $18,000 | |
| 11/14/2023 | Q3 2023 | -$0.20 | $0.28 | 0.48 | $87,000 | |
| 08/10/2023 | Q2 2023 | -$0.21 | -$0.21 | 0 | $172,000 | |
| 05/11/2023 | Q1 2023 | -$0.22 | -$0.21 | 0.01 | $37,000 | |
| 03/24/2023 | Q4 2022 | -$0.23 | -$0.29 | -0.06 | $38,000 | |
| 11/10/2022 | Q3 2022 | -$0.23 | -$0.22 | 0.01 | $24,000 | |
| 08/15/2022 | Q2 2022 | -$0.22 | -$0.20 | 0.02 | $170,000 | |
| 05/16/2022 | Q1 2022 | -$0.25 | -$0.21 | 0.04 | $0 | |
| 03/30/2022 | Q4 2021 | -$0.23 | -$0.59 | -0.36 | $230,000 | |
| 11/15/2021 | Q3 2021 | -$0.28 | -$0.21 | 0.07 | $266,000 | |
| 08/16/2021 | Q2 2021 | -$0.13 | -$0.37 | -0.24 | $0 | |
| 03/30/2021 | Q1 2021 | $0.00 | $19.88 M | |||
| 12/30/2020 | Q4 2020 | -$0.57 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.55 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.11 | $0 | |||
| 03/30/2020 | Q1 2020 | $0.11 | $0 |
Atai Life Sciences N.V. Earnings: Frequently Asked Questions
-
When is Atai Life Sciences N.V.'s earnings date?
Atai Life Sciences N.V. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
How can I listen to Atai Life Sciences N.V.'s earnings conference call?
The conference call for Atai Life Sciences N.V.'s latest earnings report can be listened to online.
-
How can I read Atai Life Sciences N.V.'s conference call transcript?
The conference call transcript for Atai Life Sciences N.V.'s latest earnings report can be read online.
-
How much revenue does Atai Life Sciences N.V. generate each year?
Atai Life Sciences N.V. (:ATAI) has a recorded annual revenue of $314,000.
-
How much profit does Atai Life Sciences N.V. generate each year?
Atai Life Sciences N.V. (:ATAI) has a recorded net income of $314,000. Atai Life Sciences N.V. has generated $-0.25 earnings per share over the last four quarters.
-
What is Atai Life Sciences N.V.'s price-to-earnings ratio?
Atai Life Sciences N.V. (:ATAI) has a price-to-earnings ratio of -2.09 and price/earnings-to-growth ratio is 0.02.
